These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18383596)

  • 41. Identification of a novel KRIT1 mutation in an Italian family with cerebral cavernous malformation by the protein truncation test.
    Marini V; Ferrera L; Dorcaratto A; Viale G; Origone P; Mareni C; Garrè C
    J Neurol Sci; 2003 Aug; 212(1-2):75-8. PubMed ID: 12810002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations.
    Gault J; Sain S; Hu LJ; Awad IA
    Neurosurgery; 2006 Dec; 59(6):1278-84; discussion 1284-5. PubMed ID: 17277691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CCM3 mutations are uncommon in cerebral cavernous malformations.
    Verlaan DJ; Roussel J; Laurent SB; Elger CE; Siegel AM; Rouleau GA
    Neurology; 2005 Dec; 65(12):1982-3. PubMed ID: 16380626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial cerebral cavernomas due to a KRIT1 mutation presenting with epilepsy.
    Rajakulendran S; Andole S; Kennedy A
    BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22699465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cavernous malformation within a schwannoma: review of the literature and hypothesis of a common genetic etiology.
    Feiz-Erfan I; Zabramski JM; Herrmann LL; Coons SW
    Acta Neurochir (Wien); 2006 Jun; 148(6):647-52; discussion 652. PubMed ID: 16450046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial multiple cavernomatosis: description of a new mutation.
    Simón Gozalbo A; Beneyto M; Rodríguez-Luna D; Vilar Ventura RM; Belenguer Benavides A; Geffner Sclarsky D
    Neurologia; 2011 Apr; 26(3):184-6. PubMed ID: 21163227
    [No Abstract]   [Full Text] [Related]  

  • 47. Angioleiomyomas of the dura: rare entities that lack KRIT1 mutations.
    Conner TM; Waziri A; Kleinschmidt-Demasters BK
    Am J Surg Pathol; 2012 Apr; 36(4):526-33. PubMed ID: 22261708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel human pathological mutations. Gene symbol: MEN1. Disease: MEN1, Multiple endocrine neoplasia, type 1.
    Wenzel JJ; Rossmann H; Lackner KJ; Musholt TJ
    Hum Genet; 2007 Nov; 122(3-4):416. PubMed ID: 18350655
    [No Abstract]   [Full Text] [Related]  

  • 49. Status epilepsy in CCM with KRIT1 gene change.
    Craft EV; Vasudevan PC
    Eur J Paediatr Neurol; 2014 Mar; 18(2):241-2. PubMed ID: 24238821
    [No Abstract]   [Full Text] [Related]  

  • 50. Search for loss of heterozygosity and mutation analysis of KRIT1 gene in CCM patients.
    Marini V; Ferrera L; Pigatto F; Origone P; Garrè C; Dorcaratto A; Viale G; Alberti F; Mareni C
    Am J Med Genet A; 2004 Sep; 130A(1):98-101. PubMed ID: 15368504
    [No Abstract]   [Full Text] [Related]  

  • 51. Cavernous malformations of the central nervous system combined with cutaneous vascular lesions due to KRIT1 mutation: a case report.
    Lan MY; Liu YF; Huang CC; Peng CH; Liu JS; Chang YY
    Clin Neurol Neurosurg; 2010 Oct; 112(8):729-32. PubMed ID: 20646827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1).
    Kehrer-Sawatzki H; Wilda M; Braun VM; Richter HP; Hameister H
    Acta Neuropathol; 2002 Sep; 104(3):231-40. PubMed ID: 12172908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A novel Krit-1 mutation in Han family with cerebral cavernous malformation].
    Xu YL; Zhao JZ; Wu BQ; Zhong HH; Wang S; Heng WJ
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):220-5. PubMed ID: 12882686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral cavernous malformations associated with cutaneous angiokeratomas and hemangiomas.
    Whitworth WW; Hick RW; Nelson KC; Sidhu-Malik NK
    Cutis; 2015 Nov; 96(5):329-32. PubMed ID: 26682556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sorting nexin 17, a non-self-assembling and a PtdIns(3)P high class affinity protein, interacts with the cerebral cavernous malformation related protein KRIT1.
    Czubayko M; Knauth P; Schlüter T; Florian V; Bohnensack R
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1264-72. PubMed ID: 16712798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral cavernous malformations and unilateral moyamoya in a patient with a new mutation in the KRIT-1 /CCM1 gene.
    Melis M; Cau M; Corraine S; Secci S; Addis M; Melis M
    Cerebrovasc Dis; 2014; 38(4):311-2. PubMed ID: 25413039
    [No Abstract]   [Full Text] [Related]  

  • 57. Krit1/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult.
    Denier C; Gasc JM; Chapon F; Domenga V; Lescoat C; Joutel A; Tournier-Lasserve E
    Mech Dev; 2002 Sep; 117(1-2):363-7. PubMed ID: 12204286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blue papules in a patient with neurologic symptoms.
    Wang CM; Motaparthi K; Grekin SJ; Hsu S
    JAMA Dermatol; 2013 Jan; 149(1):97-102. PubMed ID: 23324766
    [No Abstract]   [Full Text] [Related]  

  • 59. Study of cerebral cavernous malformation in Spain and Portugal: high prevalence of a 14 bp deletion in exon 5 of MGC4607 (CCM2 gene).
    Ortiz L; Costa AF; Bellido ML; Solano F; García-Moreno JM; Gamero MA; Izquierdo G; Chadli A; Falcao F; Ferro J; Salas J; Alvarez-Cermeño JC; Montori M; Ramos-Arroyo MA; Palomino A; Pintado E; Lucas M
    J Neurol; 2007 Mar; 254(3):322-6. PubMed ID: 17345049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations.
    Zhang J; Rigamonti D; Dietz HC; Clatterbuck RE
    Neurosurgery; 2007 Feb; 60(2):353-9; discussion 359. PubMed ID: 17290187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.